IL190245A0 - Iontophoretic drug delivery system - Google Patents
Iontophoretic drug delivery systemInfo
- Publication number
- IL190245A0 IL190245A0 IL190245A IL19024508A IL190245A0 IL 190245 A0 IL190245 A0 IL 190245A0 IL 190245 A IL190245 A IL 190245A IL 19024508 A IL19024508 A IL 19024508A IL 190245 A0 IL190245 A0 IL 190245A0
- Authority
- IL
- Israel
- Prior art keywords
- delivery system
- drug delivery
- iontophoretic drug
- iontophoretic
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/0436—Material of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0444—Membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0448—Drug reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
- A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72213605P | 2005-09-30 | 2005-09-30 | |
PCT/US2006/038549 WO2007041544A1 (fr) | 2005-09-30 | 2006-09-29 | Systemes d'administration transdermique de medicament, dispositifs, et methodes faisant intervenir un agoniste opioide et/ou un antagoniste opioide |
Publications (1)
Publication Number | Publication Date |
---|---|
IL190245A0 true IL190245A0 (en) | 2008-11-03 |
Family
ID=37696075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL190245A IL190245A0 (en) | 2005-09-30 | 2008-03-18 | Iontophoretic drug delivery system |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1931421A1 (fr) |
JP (1) | JP2009509692A (fr) |
KR (1) | KR20080058433A (fr) |
CN (2) | CN101321554A (fr) |
AU (1) | AU2006299521A1 (fr) |
BR (1) | BRPI0616788A2 (fr) |
CA (1) | CA2622684A1 (fr) |
IL (1) | IL190245A0 (fr) |
RU (1) | RU2008117168A (fr) |
WO (1) | WO2007041544A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100239523A1 (en) * | 2007-10-30 | 2010-09-23 | The Regents Of The University Of Colorado | Tlr modulators and methods for using the same |
CA2719134C (fr) | 2008-03-21 | 2015-06-30 | The University Of Chicago | Traitement avec des antagonistes des opioides et des inhibiteurs mtor |
WO2010036401A1 (fr) | 2008-05-01 | 2010-04-01 | The Regents Of The University Of California | Méthodes et compositions utilisant des agonistes des récepteurs 1 aux opioïdes de type delta |
WO2010110397A1 (fr) * | 2009-03-25 | 2010-09-30 | 国立大学法人 香川大学 | Micro-aiguilles, et leur procédé de fabrication et leur moule |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
CN106730311B (zh) * | 2016-12-27 | 2019-10-29 | 潍坊大地医疗器械有限公司 | 经络综合治疗仪电极触头装置 |
WO2018129304A1 (fr) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Dispositifs et methodes d'administration transdermique de medicament |
GB201704909D0 (en) * | 2017-03-28 | 2017-05-10 | Ldn Pharma Ltd | Cancer therapy |
WO2019090125A2 (fr) * | 2017-11-02 | 2019-05-09 | Chrono Therapeutics Inc. | Système d'administration de médicament transdermique anti-abus intelligent |
AU2019279884A1 (en) | 2018-05-29 | 2020-12-10 | Morningside Venture Investments Limited | Drug delivery methods and systems |
WO2020172498A1 (fr) | 2019-02-21 | 2020-08-27 | Pharmaceutical Productions, Inc. | Préparations de naloxone à administrer par voie sublinguale et/ou buccale |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
US4722726A (en) * | 1986-02-12 | 1988-02-02 | Key Pharmaceuticals, Inc. | Method and apparatus for iontophoretic drug delivery |
US4879297A (en) * | 1987-06-01 | 1989-11-07 | Warner-Lambert Company | Fatty acids and their small chain esters as penetration enhancers in aqueous systems |
US5312326A (en) * | 1992-06-02 | 1994-05-17 | Alza Corporation | Iontophoretic drug delivery apparatus |
PT1646328E (pt) * | 2003-07-25 | 2007-10-24 | Euro Celtique Sa | Tratamento da abstinência de dependência. |
TW200640526A (en) * | 2005-02-24 | 2006-12-01 | Alza Corp | Transdermal electrotransport drug delivery systems with reduced abuse potential |
-
2006
- 2006-09-29 CA CA002622684A patent/CA2622684A1/fr not_active Abandoned
- 2006-09-29 BR BRPI0616788-8A patent/BRPI0616788A2/pt not_active Application Discontinuation
- 2006-09-29 JP JP2008533767A patent/JP2009509692A/ja not_active Withdrawn
- 2006-09-29 CN CNA2006800450261A patent/CN101321554A/zh active Pending
- 2006-09-29 EP EP06816083A patent/EP1931421A1/fr not_active Withdrawn
- 2006-09-29 AU AU2006299521A patent/AU2006299521A1/en not_active Abandoned
- 2006-09-29 WO PCT/US2006/038549 patent/WO2007041544A1/fr active Application Filing
- 2006-09-29 CN CNA2006800449368A patent/CN101316623A/zh active Pending
- 2006-09-29 KR KR1020087010036A patent/KR20080058433A/ko not_active Application Discontinuation
- 2006-09-29 RU RU2008117168/14A patent/RU2008117168A/ru unknown
-
2008
- 2008-03-18 IL IL190245A patent/IL190245A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101316623A (zh) | 2008-12-03 |
WO2007041544A1 (fr) | 2007-04-12 |
BRPI0616788A2 (pt) | 2011-07-05 |
EP1931421A1 (fr) | 2008-06-18 |
CA2622684A1 (fr) | 2007-04-12 |
CN101321554A (zh) | 2008-12-10 |
KR20080058433A (ko) | 2008-06-25 |
RU2008117168A (ru) | 2009-11-10 |
AU2006299521A1 (en) | 2007-04-12 |
JP2009509692A (ja) | 2009-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1901796A4 (fr) | Systeme de delivrance de medicaments | |
EP2178598A4 (fr) | Système d'administration de médicament iontophorétique | |
EP1848749A4 (fr) | Systeme de distribution de medicaments par contact | |
IL190245A0 (en) | Iontophoretic drug delivery system | |
IL184824A0 (en) | Infusion delivery system | |
GB2442875B (en) | Regulated drug delivery system | |
IL169807A (en) | Device for administering a drug | |
EP1793865A4 (fr) | Systeme de distribution de medicament ou de gene | |
EP1773240A4 (fr) | Systeme d'administration de medicament a base de soie | |
IL187457A0 (en) | Breath actuated drug delivery system | |
GB0522569D0 (en) | Biocompatible drug delivery device | |
IL177785A0 (en) | Nanocell drug delivery system | |
ZA201002014B (en) | Drug delivery system | |
PL1631255T3 (pl) | System dostarczania leków | |
IL198911A0 (en) | Drug delivery | |
EP1755732A4 (fr) | Systeme d'administration de medicament en doses unitaires multiples | |
EP1858483A4 (fr) | Systeme d'administration pour de multiples medicaments | |
HK1202083A1 (en) | Iontophoretic drug delivery system | |
GB0517035D0 (en) | Delivery system | |
PL1957073T3 (pl) | Substancja lecznicza | |
IL176395A0 (en) | Nicotine transdermal delivery system | |
EP1858493A4 (fr) | Systeme d'administration de medicament par voie orale | |
EP2226083A4 (fr) | Système d'administration de médicament | |
GB0515363D0 (en) | Drug delivery system | |
GB0401008D0 (en) | Drug delivery system |